“ATAT’s Quarterly Earnings Release: A Preview by Atour Lifestyle Holdings”
Get the latest on Atour Lifestyle Holdings' upcoming quarterly earnings, expecting an EPS of $0.46 and revenue of $405.1m. Discover what drives ATAT's impressive performance, understand its robust financial metrics, and examine its strategic growth plans amid changing industry dynamics. Join investors and analysts in monitoring ATAT's rising footprint in the hospitality market. Read more
Read More
“Financial Overview and Insights: Mineralys Therapeutics Inc. (NASDAQ:MLYS)”
Jefferies analyst sets a promising $30 price target for biopharmaceutical company, Mineralys Therapeutics (NASDAQ:MLYS), predicting a 14.37% surge. MLYS's focus on cardiovascular and renal disease treatments, solid Q4 2025 earnings report and active trading volume positions it as a potentially lucrative investment, despite recent market volatility. Read more
Read More
“VEON Prepares for Earnings Amid Pakistan Spectrum Acquisition”
Global digital operator, VEON Ltd. prepares to release its quarterly earnings, backed by the thriving market position of its subsidiary, Jazz, in Pakistan. With Wall Street analysts projecting an EPS of $1.33 and a revenue close to $1.12 billion, approaching earnings herald a critical financial milestone for VEON. Read more
Read More